RNA-based therapeutics for colorectal cancer: Updates and future directions.

Liu, Jingwen; Guo, Bin

Liu, Jingwen; Guo, Bin.

Afiliación

Liu J; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77030, United States. Electronic address: jliu79@central.uh.edu.
Guo B; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77030, United States. Electronic address: bguo3@uh.edu.

Pharmacol Res ; 152: 104550, 2020 02.

Article en En | MEDLINE | ID: mdl-31866285

Asunto(s)

Neoplasias Colorrectales/terapia; ARN/uso terapéutico; Animales; Humanos; Resultado del Tratamiento

Palabras clave

5-Fluorouracil (PubChem CID: 3385); Capecitabine (PubChem CID: 60953); Chemical modifications; Clinical trials; Colorectal cancer; Doxorubicin (PubChem CID: 31703); Etoposide (PubChem CID: 36462); Gene delivery; Irinotecan (PubChem CID: 60838); Leucovorin (PubChem CID: 135403648); Paclitaxel (PubChem CID: 36314); RNA interference; RNA-based therapeutics; Tipiracil (PubChem CID: 6323266); Trifluridine (PubChem CID: 6256); Vinblastine (PubChem CID: 241903)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ARN / Neoplasias Colorrectales Límite: Animals / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google